Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Inv. presentation Appointed director Notes underwriting agrmnt
|
Ayala Pharmaceuticals, Inc. (ADXS)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
02/08/2023 |
SC 13G
| Redmile Group, LLC reports a 6.8% stake in AYALA PHARMACEUTICALS, Inc. |
01/30/2023 |
SC 13G
| Schindel Yair Chaim reports a 12.2% stake in Ayala Pharmaceutics, Inc |
08/03/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
02/13/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
01/30/2020 |
SC 13G
| CVI Investments, Inc. reports a 8.3% stake in Advaxis, Inc. |
07/31/2019 |
SC 13G
| Altium Capital Management LP reports a 9.9% stake in Advaxis, Inc |
04/12/2019 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
04/09/2019 |
SC 13G
| Anson Funds Management LP reports a 7.5% stake in Advaxis, Inc. |
04/03/2019 |
SC 13G
| SABBY MANAGEMENT, LLC reports a 7.5% stake in Advaxis, Inc. |
09/14/2018 |
SC 13G
| CVI Investments, Inc. reports a 6% stake in Advaxis, Inc. |
01/30/2017 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
08/02/2016 |
SC 13G
| Advaxis, Inc. reports a 8.9% stake in ADVAXIS, INC. |
02/12/2016 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
10/30/2013 |
SC 13G
| KEENER JUSTIN reports a 6% stake in ADvaxis, inc. |
10/24/2013 |
SC 13G
| SABBY MANAGEMENT, LLC reports a 6.3% stake in Advaxis, Inc. |
01/11/2010 |
SC 13G
| Advaxis, Inc. reports a 10% stake in ADVAXIS, INC. |
|
|